Literature DB >> 16876134

Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats.

Cindy K Funk1, Eric P Zorrilla, Mei-Jing Lee, Kenner C Rice, George F Koob.   

Abstract

BACKGROUND: Alcohol dependence is characterized by excessive alcohol consumption, loss of control over intake, and the presence of a withdrawal syndrome, which includes both motivational and physical symptoms. Similar to human alcoholics, ethanol-dependent animals display enhanced anxiety-like behaviors and enhanced ethanol self-administration during withdrawal, effects hypothesized to result from a dysregulation of corticotropin-releasing factor (CRF) stress systems. Here, we used an animal model of ethanol dependence to test the effects of CRF(1) receptor antagonists on excessive ethanol self-administration in dependent rats.
METHODS: Wistar rats, trained to orally self-administer ethanol, were exposed intermittently to ethanol vapors to induce ethanol dependence. Nondependent animals were exposed to control air. Following a 2-hour period of withdrawal, dependent and nondependent animals were systemically administered antalarmin, MJL-1-109-2, or R121919 (CRF(1) antagonists) and ethanol self-administration was measured.
RESULTS: The nonpeptide, small molecule CRF(1) antagonists selectively reduced excessive self-administration of ethanol in dependent animals during acute withdrawal. The antagonists had no effect on ethanol self-administration in nondependent rats.
CONCLUSIONS: These data demonstrate that CRF(1) receptors play an important role in mediating excessive ethanol self-administration in dependent rats, with no effect in nondependent rats. CRF(1) antagonists may be exciting new pharmacotherapeutic targets for the treatment of alcoholism in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876134      PMCID: PMC2741496          DOI: 10.1016/j.biopsych.2006.03.063

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  92 in total

1.  The effect of isolation rearing on volitional ethanol consumption and central CCK/dopamine systems in Fawn-Hooded rats.

Authors:  Daniel J Lodge; Andrew J Lawrence
Journal:  Behav Brain Res       Date:  2003-05-15       Impact factor: 3.332

Review 2.  Neuroadaptive mechanisms of addiction: studies on the extended amygdala.

Authors:  George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2003-12       Impact factor: 4.600

3.  Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist.

Authors:  Glenn R Valdez; Eric P Zorrilla; Jean Rivier; Wylie W Vale; George F Koob
Journal:  Brain Res       Date:  2003-08-08       Impact factor: 3.252

4.  Autoradiographic visualization of corticotropin releasing hormone type 1 receptors with a nonpeptide ligand: synthesis of [(76)Br]MJL-1-109-2.

Authors:  Elaine Jagoda; Carlo Contoreggi; Mei-Jing Lee; Chih-Hao K Kao; Lawrence P Szajek; Sam Listwak; Philip Gold; George Chrousos; Elisabeth Greiner; B Moon Kim; Arthur E Jacobson; Kenner C Rice; William Eckelman
Journal:  J Med Chem       Date:  2003-08-14       Impact factor: 7.446

5.  Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

Authors:  Marianne B Müller; Stephan Zimmermann; Inge Sillaber; Thomas P Hagemeyer; Jan M Deussing; Peter Timpl; Michael S D Kormann; Susanne K Droste; Ralf Kühn; Johannes M H M Reul; Florian Holsboer; Wolfgang Wurst
Journal:  Nat Neurosci       Date:  2003-09-14       Impact factor: 24.884

6.  Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775.

Authors:  Akihiko Oshima; Cornelia Flachskamm; Johannes M H M Reul; Florian Holsboer; Astrid C E Linthorst
Journal:  Neuropsychopharmacology       Date:  2003-12       Impact factor: 7.853

7.  Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects.

Authors:  Heike E Künzel; Astrid W Zobel; Thomas Nickel; Nibal Ackl; Manfred Uhr; Annette Sonntag; Marcus Ising; Florian Holsboer
Journal:  J Psychiatr Res       Date:  2003 Nov-Dec       Impact factor: 4.791

8.  Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence.

Authors:  Glenn R Valdez; Eric P Zorrilla; Amanda J Roberts; George F Koob
Journal:  Alcohol       Date:  2003-02       Impact factor: 2.405

9.  Reduced 5-HT3 receptor binding and lower baseline plus maze anxiety in the alcohol-preferring inbred fawn-hooded rat.

Authors:  Julie G Hensler; Clyde W Hodge; David H Overstreet
Journal:  Pharmacol Biochem Behav       Date:  2004-02       Impact factor: 3.533

10.  The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats.

Authors:  Subhash C Pandey; Adip Roy; Huaibo Zhang
Journal:  Alcohol Clin Exp Res       Date:  2003-03       Impact factor: 3.455

View more
  178 in total

Review 1.  Preclinical studies of alcohol binge drinking.

Authors:  John C Crabbe; R Adron Harris; George F Koob
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  The neurobiology of binge-like ethanol drinking: evidence from rodent models.

Authors:  Gretchen M Sprow; Todd E Thiele
Journal:  Physiol Behav       Date:  2012-01-08

3.  Effects of CB1 and CRF1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: lack of withdrawal-like responses.

Authors:  Sarah L Parylak; Pietro Cottone; Valentina Sabino; Kenner C Rice; Eric P Zorrilla
Journal:  Physiol Behav       Date:  2012-07-06

4.  Effects of prolonged ethanol vapor exposure on forced swim behavior, and neuropeptide Y and corticotropin-releasing factor levels in rat brains.

Authors:  Brendan M Walker; David A Drimmer; Jennifer L Walker; Tianmin Liu; Aleksander A Mathé; Cindy L Ehlers
Journal:  Alcohol       Date:  2010-08-12       Impact factor: 2.405

Review 5.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

6.  Commentary: studies on binge-like ethanol drinking may help to identify the neurobiological mechanisms underlying the transition to dependence.

Authors:  Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2012-02       Impact factor: 3.455

Review 7.  Influence of stress associated with chronic alcohol exposure on drinking.

Authors:  Howard C Becker
Journal:  Neuropharmacology       Date:  2017-04-19       Impact factor: 5.250

8.  Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats.

Authors:  Thomas N Greenwell; Cindy K Funk; Pietro Cottone; Heather N Richardson; Scott A Chen; Kenner C Rice; Eric P Zorrilla; George F Koob
Journal:  Addict Biol       Date:  2009-04       Impact factor: 4.280

9.  Enhanced GABAergic transmission in the central nucleus of the amygdala of genetically selected Marchigian Sardinian rats: alcohol and CRF effects.

Authors:  Melissa A Herman; Marsida Kallupi; George Luu; Christopher S Oleata; Markus Heilig; George F Koob; Roberto Ciccocioppo; Marisa Roberto
Journal:  Neuropharmacology       Date:  2012-12-04       Impact factor: 5.250

10.  Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking.

Authors:  Andrea Cippitelli; Ruslan Damadzic; Anita C Hansson; Erick Singley; Wolfgang H Sommer; Robert Eskay; Annika Thorsell; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2009-12-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.